Astrotech Corporation (DE) Common Stock vs. 10x Genomics, Inc. Class A Common Stock
ASTC
Astrotech Corporation (DE) Common Stock
$9.01 -1.10%
VS TXG10x Genomics, Inc. Class A Common Stock
$45.60 -3.92%
10x Genomics, Inc. Class A Common Stock (TXG) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ASTC | TXG | |
|---|---|---|
| Market Cap | $18.10 million | $5.79 billion |
| Revenue (TTM) | $959,000 | $638.78 million |
| Net Income (TTM) | $-14,091,000 | $-22,656,000 |
TXG leads on 2 of 3 size & scale factors.
Valuation
| ASTC | TXG | |
|---|---|---|
| Price / Book | 1.49 | 7.11 |
| Price / Sales | 18.88 | 9.06 |
ASTC and TXG split the valuation factors evenly.
Profitability
| ASTC | TXG | |
|---|---|---|
| Net Margin | -1469.34% | -3.55% |
| Return on Equity | -115.93% | -2.78% |
TXG leads on 2 of 2 profitability factors.
Risk & Sentiment
| ASTC | TXG | |
|---|---|---|
| Short Interest | 1.71% | 0.43% |
TXG leads on 1 of 1 risk & sentiment factors.
Dig deeper: ASTC overview, ASTC financials, TXG overview, TXG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.